"Metabolic Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
Descriptor ID |
D024821
|
MeSH Number(s) |
C18.452.394.968.500.570 C18.452.625
|
Concept/Terms |
Metabolic Syndrome- Metabolic Syndrome
- Metabolic Syndromes
- Syndrome, Metabolic
- Syndromes, Metabolic
- Metabolic Syndrome X
- Insulin Resistance Syndrome X
- Syndrome X, Metabolic
- Syndrome X, Insulin Resistance
- Metabolic X Syndrome
- Syndrome, Metabolic X
- X Syndrome, Metabolic
- Dysmetabolic Syndrome X
- Syndrome X, Dysmetabolic
- Reaven Syndrome X
- Syndrome X, Reaven
- Metabolic Cardiovascular Syndrome
- Cardiovascular Syndrome, Metabolic
- Cardiovascular Syndromes, Metabolic
- Syndrome, Metabolic Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Metabolic Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Metabolic Syndrome".
This graph shows the total number of publications written about "Metabolic Syndrome" by people in this website by year, and whether "Metabolic Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 3 | 2 | 5 |
2007 | 3 | 0 | 3 |
2008 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2010 | 1 | 1 | 2 |
2012 | 1 | 0 | 1 |
2013 | 0 | 1 | 1 |
2017 | 2 | 0 | 2 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Metabolic Syndrome" by people in Profiles.
-
Early life factors and their relevance for markers of cardiometabolic risk in early adulthood. Nutr Metab Cardiovasc Dis. 2021 06 30; 31(7):2109-2121.
-
Developmental trajectories of body mass index from childhood into late adolescence and subsequent late adolescence-young adulthood cardiometabolic risk markers. Cardiovasc Diabetol. 2019 01 19; 18(1):9.
-
Identification of Comprehensive Metabotypes Associated with Cardiometabolic Diseases in the Population-Based KORA Study. Mol Nutr Food Res. 2018 08; 62(16):e1800117.
-
Plasma Concentrations of Afamin Are Associated With Prevalent and Incident Type 2 Diabetes: A Pooled Analysis in More Than 20,000 Individuals. Diabetes Care. 2017 10; 40(10):1386-1393.
-
Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study. Cardiovasc Diabetol. 2017 01 31; 16(1):17.
-
Epigenetic regulation of depot-specific gene expression in adipose tissue. PLoS One. 2013; 8(12):e82516.
-
Vasoregulatory peptides pro-endothelin-1 and pro-adrenomedullin are associated with metabolic syndrome in the population-based KORA F4 study. Eur J Endocrinol. 2012 Dec; 167(6):847-53.
-
Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients. Arch Physiol Biochem. 2010 May; 116(2):57-62.
-
Association of postprandial and fasting triglycerides with traits of the metabolic syndrome in the Metabolic Intervention Cohort Kiel. Eur J Endocrinol. 2010 Apr; 162(4):719-27.
-
Gene-gene interaction between APOA5 and USF1: two candidate genes for the metabolic syndrome. Obes Facts. 2009; 2(4):235-42.